ArticleCommunications medicine2026

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitis.

Parul Sirohi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.